Desulfovibrio piger
Selected indexed studies
- Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study. (J Cachexia Sarcopenia Muscle, 2022) [PMID:35851765]
- In vitro interactions between Blautia hydrogenotrophica, Desulfovibrio piger and Methanobrevibacter smithii under hydrogenotrophic conditions. (Gut Microbes, 2023) [PMID:37753963]
- Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism. (Pharmacol Res, 2024) [PMID:39293583]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Faecal microbiota transplantation halts progression of human new-onset type 1 diabetes in a randomised controlled trial. (2021) pubmed
- Fecal microbiota transplantation for hypertension: an exploratory, multicenter, randomized, blinded, placebo-controlled trial. (2025) pubmed
- In vitro interactions between Blautia hydrogenotrophica, Desulfovibrio piger and Methanobrevibacter smithii under hydrogenotrophic conditions. (2023) pubmed
- Population-based metagenomics analysis reveals altered gut microbiome in sarcopenia: data from the Xiangya Sarcopenia Study. (2022) pubmed
- Palmatine protects against atherosclerosis by gut microbiota and phenylalanine metabolism. (2024) pubmed
- Human gut strains of Desulfovibrio piger exhibit spontaneous induction of multiple prophages. (2025) pubmed
- Age-dependent changes in the gut microbiota and serum metabolome correlate with renal function and human aging. (2023) pubmed
- Toxicity of hydrogen sulfide toward sulfate-reducing bacteria Desulfovibrio piger Vib-7. (2019) pubmed
- Complete Genome Sequence of Desulfovibrio piger FI11049. (2017) pubmed
- Synergy and oxygen adaptation for development of next-generation probiotics. (2023) pubmed